The first endoscopic intraluminal gastroplasty in the treatment of a patient with morbid obesity

Introduction. Endoscopic gastroplasty is a minimally invasive and, importantly, reversible method for treating patients with morbid obesity, performed transorally. The restrictive effect of this intervention is achieved by reducing the volume of the stomach, similar to laparoscopic sleeve resection, through the endoscopic placement of numerous endoluminal sutures that pass through all the walls of the stomach - starting from the antral part and extending to the upper third of the body of the stomach. The Apollo Overstitch™ system is used for this procedure. It is worth noting that this device was registered in the Russian Federation in 2024. Clinical observation. A 34-year-old female patient underwent endoscopic treatment at the A.V. Vishnevsky National Medical Research Center of Surgery for grade 3 morbid obesity. Results. In our clinical observation, we achieved convincing results in the treatment of a patient with grade 3 morbid obesity. The endoscopic approach used for performing gastroplasty not only allowed for a complete gastric restriction similar to laparoscopic sleeve gastrectomy but also minimized postoperative complications. Conclusion. Endoscopic gastroplasty in the treatment of patients with morbid obesity is an optimal, modern technique and a preferred alternative to traditional surgical interventions. The undeniable advantages of this method include a stable functional outcome, a low level of complications, and a short postoperative period, allowing for a rapid return of patients to their usual lifestyle without the need for prolonged rehabilitation.

Endoscopic gastroplasty, morbid obesity, bariatric surgery, endoscopy, sleeve gastroplasty, endoscopic surgery

1. Funk L.M., Jolles S., Fischer L.E., Voils C.I. Patient and Referring Practitioner Characteristics Associated With the Likelihood of Undergoing Bariatric Surgery: A Systematic Review. JAMA Surg. 2015 Oct;150(10):999-1005. doi: 10.1001/jamasurg.2015.1250.

2. Hedjoudje A., Abu Dayyeh B.K., Cheskin L.J. et al. Efficacy and Safety of Endoscopic Sleeve Gastroplasty: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2020 May;18(5):1043-1053.e4. doi: 10.1016/j.cgh.2019.08.022.

3. World Health Organization. Global Health Risks: mortality and burden of disease attributable to selected major risks. (2009). http://www.who.int/healthinfo/global_burden_disease/global_health_risks/en/index.html.

4. GBD 2015 Obesity Collaborators; Afshin A., Forouzanfar M.H., Reitsma M.B. et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med. 2017 Jul 6;377(1):13-27. doi: 10.1056/NEJMoa1614362.

5. Carlsson L.M.S., Sjöholm K., Jacobson P. et al. Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study. N Engl J Med. 2020 Oct 15;383(16):1535-1543. doi: 10.1056/NEJMoa2002449.

6. Welbourn, R., Hollyman, M., Kinsman, R. et al. Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Fourth IFSO Global Registry Report 2018. OBES SURG. 2019;(29): 782-795. doi: 10.1007/s11695-018-3593-1.

7. Khatsiev B.B., Akhmetov A.D., Kuzminov A.N., Mitsinskaya A.I., Mitsinskii M.A. Bareoreg: Russian national bariatric registry. Endoscopic Surgery. 2019;25(4):23-33. (In Russ.) doi: 10.17116/endoskop20192504123.@@ Хациев Б.Б., Ахметов А.Д., Кузьминов А.Н., Мицинская А.И., Мицинский М.А. Bareoreg: Российский национальный бариатрический реестр - система регистрации больных с морбидным ожирением. Эндоскопическая хирургия. 2019;25(4):23-33. doi: 10.17116/endoskop20192504123.

8. Brunaldi V.O., Neto M.G. Endoscopic sleeve gastroplasty: a narrative review on historical evolution, physiology, outcomes, and future standpoints. Chin Med J (Engl). 2022 Apr 5;135(7):774-778. doi: 10.1097/CM9.0000000000002098.

9. ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee; Abu Dayyeh B.K., Kumar N., Edmundowicz S.A., Jonnalagadda S., Larsen M., Sullivan S., Thompson C.C., Banerjee S. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015 Sep;82(3):425-38.e5. doi: 10.1016/j.gie.2015.03.1964.

10. ASGE/ASMBS Task Force on Endoscopic Bariatric Therapy; Ginsberg G.G., Chand B., Cote G.A., Dallal R.M., Edmundowicz S.A., Nguyen N.T., Pryor A., Thompson C.C. A pathway to endoscopic bariatric therapies. Gastrointest Endosc. 2011 Nov;74(5):943-53. doi: 10.1016/j.gie.2011.08.053.

11. Dayyeh B.K.A., Stier C., Alqahtani A. et al. IFSO Bariatric Endoscopy Committee Evidence-Based Review and Position Statement on Endoscopic Sleeve Gastroplasty for Obesity Management. Obes Surg. 2024 Dec;34(12):4318-4348. doi: 10.1007/s11695-024-07510-z.

12. Lopez-Nava G., Sharaiha R.Z., Vargas E.J. et al. Endoscopic Sleeve Gastroplasty for Obesity: a Multicenter Study of 248 Patients with 24 Months Follow-Up. Obes Surg. 2017 Oct;27(10):2649-2655. doi: 10.1007/s11695-017-2693-7.

13. Angrisani L., Santonicola A., Iovino P., Palma R., Kow L., Prager G., Ramos A., Shikora S.; Collaborative Study Group for the IFSO Worldwide Survey. IFSO Worldwide Survey 2020-2021: Current Trends for Bariatric and Metabolic Procedures. Obes Surg. 2024 Apr;34(4):1075-1085. doi: 10.1007/s11695-024-07118-3.